Addiction MedsMedicationsOpioidsResearchSubstance UseBuprenorphine vs Naltrexone: A Large StudyJuly 15, 2026by Chris Aiken, MD0
Addiction MedsDisordersMed-PsychOpioidsResearchSubstance UseMatching Opioid MAT for Complex PatientsJuly 10, 2026by Chris Aiken, MD0
AlcoholOpioidsResearchSubstance UseBuprenorphine and Naltrexone for Impaired PhysiciansJune 17, 2026by Chris Aiken, MD0
AlcoholMedicationsResearchSubstance UseTopiramate and Naltrexone Reduce Alcohol Through Common MechanismJune 9, 2026by Chris Aiken, MD0
Addiction MedsAlcoholResearchSubstance UseFDA Moves the Goalposts on Alcohol TreatmentJune 2, 2026by Chris Aiken, MD0
AlcoholGLP1 AgonistsMedicationsResearchResearch for the PublicSubstance UseTop ResearchA GLP-1 Trial Changes the Score in AlcoholMay 5, 2026by Chris Aiken, MD0
Addiction MedsAlcoholMedicationsResearchSubstance UseTop ResearchNaltrexone-Baclofen Combo for Alcohol CravingApril 28, 2026by Chris Aiken, MD1
Addiction MedsDepressionInflammationResearchLow Dose Naltrexone in DepressionMarch 23, 2026by Chris Aiken, MD0